ACT Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.06M Sell
2022
Q2
$3.87M Hold
2022
Q1
$3.93M Hold
2021
Q4
$4.13M Buy
2021
Q3
$2.09M Buy
2021
Q2
$1.3M Buy